Herpes simplex virus type 2 infection as a biomarker for sexual debut among young people in sub-Saharan Africa: a literature review

2012 ◽  
Vol 23 (11) ◽  
pp. 761-766 ◽  
Author(s):  
S Bastien ◽  
A J Mason-Jones ◽  
P De Koker ◽  
E J Mmbaga ◽  
D A Ross ◽  
...  
2021 ◽  
Vol 35 ◽  
pp. 100876
Author(s):  
Manale Harfouche ◽  
Farah M. Abu-Hijleh ◽  
Charlotte James ◽  
Katharine J. Looker ◽  
Laith J. Abu-Raddad

2011 ◽  
Vol 18 (7) ◽  
pp. 1191-1193 ◽  
Author(s):  
Jérôme LeGoff ◽  
Gérard Grésenguet ◽  
Chrysostome Gody ◽  
Jean De Dieu Longo ◽  
Nzambi Khonde ◽  
...  

ABSTRACTThe BioPlex platform was evaluated for the detection of herpes simplex virus 2 (HSV-2) antibodies in sub-Saharan Africa individuals in comparison to clinicovirological standards and compared to HerpeSelect. The sensitivities and specificities were, respectively, 88.9% and 93.5% for BioPlex and 89.9% and 92.7% for HerpeSelect. The agreement between both assays was 95.7%.


2021 ◽  
Author(s):  
Manale Harfouche ◽  
Farah M. Abu-Hijleh ◽  
Charlotte James ◽  
Katharine J. Looker ◽  
Laith J. Abu-Raddad

AbstractBackgroundHerpes simplex virus type 2 (HSV-2) infection is a prevalent sexually transmitted infection with a sizable disease burden that is highest in sub-Saharan Africa. This study aimed to characterize HSV-2 epidemiology in this region.MethodsCochrane and PRISMA guidelines were followed to systematically review, synthesize, and report HSV-2 related findings. Meta-analyses and meta-regressions were conducted.FindingsFrom 218 relevant publications, 451 overall outcome measures and 869 stratified measures were extracted. Pooled incidence rates ranged between 2.4-19.4 per 100 person-years across populations. Pooled seroprevalence was lowest at 37.3% (95% confidence interval (CI): 34.9-39.7%) in general populations and high in female sex workers and HIV positive individuals at 62.5% (95% CI: 54.8-70.0%) and 71.3% (95% CI: 66.5-75.9%), respectively. In general populations, pooled seroprevalence increased steadily with age. Compared to women, men had a lower seroprevalence with an adjusted risk ratio (ARR) of 0.61 (95% CI: 0.56-0.67).Seroprevalence decreased in recent decades with an ARR of 0.98 (95% CI: 0.97-0.99) per year. Seroprevalence was highest in Eastern and Southern Africa. Pooled HSV-2 proportion in genital ulcer disease was 50.7% (95% CI: 44.7-56.8%) and in genital herpes it was 97.3% (95% CI: 84.4-100%).InterpretationSeroprevalence is declining by 2% per year, but a third of the population is infected. Age and geography play profound roles in HSV-2 epidemiology. Temporal declines and geographic distribution of HSV-2 seroprevalence mirror that of HIV prevalence, suggesting sexual risk behavior has been declining for three decades. HSV-2 is the etiological cause of half of GUD and nearly all genital herpes cases.FundingThis work was supported by pilot funding from the Biomedical Research Program at Weill Cornell Medicine in Qatar and by the Qatar National Research Fund [NPRP 9-040-3-008].


PLoS Medicine ◽  
2017 ◽  
Vol 14 (12) ◽  
pp. e1002475 ◽  
Author(s):  
Christine Johnston ◽  
Amalia Magaret ◽  
Pavitra Roychoudhury ◽  
Alexander L. Greninger ◽  
Daniel Reeves ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document